China Pharma Holdings Stock Price History
| CPHI Stock | USD 0.20 0.01 5.26% |
Below is the normalized historical share price chart for China Pharma Holdings extending back to April 17, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of China Pharma stands at 0.20, as last reported on the 28th of November, with the highest price reaching 0.20 and the lowest price hitting 0.18 during the day.
If you're considering investing in China Stock, it is important to understand the factors that can impact its price. China Pharma appears to be out of control, given 3 months investment horizon. China Pharma Holdings secures Sharpe Ratio (or Efficiency) of 0.033, which signifies that the company had a 0.033% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for China Pharma Holdings, which you can use to evaluate the volatility of the firm. Please makes use of China Pharma's Downside Deviation of 7.8, risk adjusted performance of 0.0259, and Mean Deviation of 4.25 to double-check if our risk estimates are consistent with your expectations.
The China Pharma's current Common Stock Shares Outstanding is estimated to increase to about 3.8 M, while Total Stockholder Equity is projected to decrease to under 7.1 M. . As of now, China Pharma's Price Fair Value is increasing as compared to previous years. China Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of April 2002 | 200 Day MA 0.2838 | 50 Day MA 0.2314 | Beta 0.711 |
China |
Sharpe Ratio = 0.033
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CPHI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.96 actual daily | 61 61% of assets are less volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average China Pharma is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Pharma by adding it to a well-diversified portfolio.
Price Book 0.6603 | Enterprise Value Ebitda (225.89) | Price Sales 0.6163 | Shares Float 7.9 M | Wall Street Target Price 3 |
China Pharma Stock Price History Chart
There are several ways to analyze China Stock price data. The simplest method is using a basic China candlestick price chart, which shows China Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 7, 2024 | 0.27 |
| Lowest Price | September 5, 2024 | 0.18 |
China Pharma November 28, 2024 Stock Price Synopsis
Various analyses of China Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell China Stock. It can be used to describe the percentage change in the price of China Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of China Stock.| China Pharma Price Daily Balance Of Power | 0.50 | |
| China Pharma Price Action Indicator | 0.02 | |
| China Pharma Price Rate Of Daily Change | 1.05 |
China Pharma November 28, 2024 Stock Price Analysis
China Stock Price History Data
The price series of China Pharma for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 0.09 with a coefficient of variation of 11.39. The prices are distributed with arithmetic mean of 0.22. The median price for the last 90 days is 0.23. The company had 1:5 stock split on 6th of March 2024.| Open | High | Low | Close | Volume | ||
11/28/2024 | 0.19 | 0.20 | 0.18 | 0.20 | ||
| 11/26/2024 | 0.19 | 0.20 | 0.18 | 0.20 | 205,825 | |
| 11/25/2024 | 0.19 | 0.21 | 0.18 | 0.20 | 332,689 | |
| 11/22/2024 | 0.20 | 0.20 | 0.19 | 0.19 | 112,999 | |
| 11/21/2024 | 0.19 | 0.20 | 0.19 | 0.20 | 103,991 | |
| 11/20/2024 | 0.19 | 0.20 | 0.19 | 0.19 | 382,616 | |
| 11/19/2024 | 0.19 | 0.21 | 0.18 | 0.19 | 417,882 | |
| 11/18/2024 | 0.18 | 0.20 | 0.18 | 0.19 | 233,171 | |
| 11/15/2024 | 0.20 | 0.20 | 0.18 | 0.19 | 279,256 | |
| 11/14/2024 | 0.20 | 0.20 | 0.20 | 0.20 | 138,360 | |
| 11/13/2024 | 0.20 | 0.21 | 0.19 | 0.20 | 236,294 | |
| 11/12/2024 | 0.20 | 0.21 | 0.18 | 0.20 | 316,480 | |
| 11/11/2024 | 0.19 | 0.21 | 0.19 | 0.20 | 336,526 | |
| 11/08/2024 | 0.23 | 0.23 | 0.19 | 0.20 | 937,575 | |
| 11/07/2024 | 0.24 | 0.24 | 0.21 | 0.23 | 460,015 | |
| 11/06/2024 | 0.24 | 0.25 | 0.21 | 0.22 | 1,013,558 | |
| 11/05/2024 | 0.25 | 0.26 | 0.24 | 0.25 | 268,028 | |
| 11/04/2024 | 0.25 | 0.26 | 0.25 | 0.26 | 271,559 | |
| 11/01/2024 | 0.26 | 0.26 | 0.25 | 0.26 | 508,370 | |
| 10/31/2024 | 0.26 | 0.26 | 0.24 | 0.26 | 218,091 | |
| 10/30/2024 | 0.25 | 0.26 | 0.24 | 0.26 | 506,779 | |
| 10/29/2024 | 0.24 | 0.27 | 0.23 | 0.26 | 535,975 | |
| 10/28/2024 | 0.24 | 0.25 | 0.23 | 0.24 | 356,194 | |
| 10/25/2024 | 0.24 | 0.24 | 0.24 | 0.24 | 172,668 | |
| 10/24/2024 | 0.24 | 0.25 | 0.24 | 0.24 | 301,435 | |
| 10/23/2024 | 0.25 | 0.26 | 0.24 | 0.24 | 242,941 | |
| 10/22/2024 | 0.23 | 0.25 | 0.23 | 0.25 | 261,147 | |
| 10/21/2024 | 0.25 | 0.26 | 0.23 | 0.24 | 262,192 | |
| 10/18/2024 | 0.25 | 0.26 | 0.24 | 0.25 | 422,366 | |
| 10/17/2024 | 0.26 | 0.26 | 0.24 | 0.25 | 170,204 | |
| 10/16/2024 | 0.23 | 0.25 | 0.23 | 0.25 | 228,104 | |
| 10/15/2024 | 0.25 | 0.25 | 0.23 | 0.23 | 347,429 | |
| 10/14/2024 | 0.24 | 0.25 | 0.23 | 0.25 | 120,041 | |
| 10/11/2024 | 0.24 | 0.24 | 0.22 | 0.24 | 349,084 | |
| 10/10/2024 | 0.23 | 0.25 | 0.23 | 0.24 | 318,352 | |
| 10/09/2024 | 0.24 | 0.25 | 0.22 | 0.23 | 178,303 | |
| 10/08/2024 | 0.27 | 0.27 | 0.24 | 0.24 | 544,378 | |
| 10/07/2024 | 0.26 | 0.28 | 0.25 | 0.27 | 967,465 | |
| 10/04/2024 | 0.26 | 0.27 | 0.24 | 0.25 | 272,790 | |
| 10/03/2024 | 0.25 | 0.26 | 0.22 | 0.26 | 1,375,732 | |
| 10/02/2024 | 0.22 | 0.26 | 0.22 | 0.26 | 1,216,928 | |
| 10/01/2024 | 0.23 | 0.24 | 0.20 | 0.22 | 487,958 | |
| 09/30/2024 | 0.25 | 0.25 | 0.22 | 0.24 | 1,003,821 | |
| 09/27/2024 | 0.26 | 0.26 | 0.23 | 0.24 | 1,701,894 | |
| 09/26/2024 | 0.22 | 0.25 | 0.22 | 0.24 | 977,766 | |
| 09/25/2024 | 0.22 | 0.22 | 0.21 | 0.22 | 65,863 | |
| 09/24/2024 | 0.21 | 0.22 | 0.21 | 0.22 | 37,665 | |
| 09/23/2024 | 0.21 | 0.22 | 0.20 | 0.21 | 49,274 | |
| 09/20/2024 | 0.21 | 0.22 | 0.21 | 0.22 | 36,567 | |
| 09/19/2024 | 0.23 | 0.23 | 0.21 | 0.22 | 169,187 | |
| 09/18/2024 | 0.21 | 0.23 | 0.21 | 0.23 | 230,776 | |
| 09/17/2024 | 0.20 | 0.23 | 0.20 | 0.23 | 295,533 | |
| 09/16/2024 | 0.22 | 0.22 | 0.19 | 0.19 | 302,395 | |
| 09/13/2024 | 0.23 | 0.23 | 0.20 | 0.23 | 256,015 | |
| 09/12/2024 | 0.23 | 0.24 | 0.20 | 0.23 | 876,772 | |
| 09/11/2024 | 0.19 | 0.24 | 0.18 | 0.24 | 1,861,447 | |
| 09/10/2024 | 0.18 | 0.19 | 0.18 | 0.19 | 222,295 | |
| 09/09/2024 | 0.18 | 0.18 | 0.17 | 0.18 | 23,983 | |
| 09/06/2024 | 0.18 | 0.18 | 0.17 | 0.18 | 99,063 | |
| 09/05/2024 | 0.18 | 0.20 | 0.18 | 0.18 | 277,445 | |
| 09/04/2024 | 0.19 | 0.20 | 0.19 | 0.19 | 255,826 |
About China Pharma Stock history
China Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for China is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in China Pharma Holdings will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing China Pharma stock prices may prove useful in developing a viable investing in China Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.4 M | 3.8 M | |
| Net Loss | -3.1 M | -3.2 M |
China Pharma Stock Technical Analysis
China Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
China Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for China Pharma's price direction in advance. Along with the technical and fundamental analysis of China Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of China to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0259 | |||
| Jensen Alpha | 0.2027 | |||
| Total Risk Alpha | (0.90) | |||
| Sortino Ratio | 0.0037 | |||
| Treynor Ratio | (0.28) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for China Stock analysis
When running China Pharma's price analysis, check to measure China Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Pharma is operating at the current time. Most of China Pharma's value examination focuses on studying past and present price action to predict the probability of China Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Pharma's price. Additionally, you may evaluate how the addition of China Pharma to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |